+

WO2002005731A1 - Matériau biocompatible expansible et stent - Google Patents

Matériau biocompatible expansible et stent Download PDF

Info

Publication number
WO2002005731A1
WO2002005731A1 PCT/US2001/022725 US0122725W WO0205731A1 WO 2002005731 A1 WO2002005731 A1 WO 2002005731A1 US 0122725 W US0122725 W US 0122725W WO 0205731 A1 WO0205731 A1 WO 0205731A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
animal
tubular structure
human
substance
Prior art date
Application number
PCT/US2001/022725
Other languages
English (en)
Inventor
George P. Teitelbaum
Original Assignee
Teitelbaum George P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teitelbaum George P filed Critical Teitelbaum George P
Priority to AU2001280618A priority Critical patent/AU2001280618A1/en
Publication of WO2002005731A1 publication Critical patent/WO2002005731A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/22—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B9/00—Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00
    • B32B9/02—Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising animal or vegetable substances, e.g. cork, bamboo, starch

Definitions

  • Tanya Hall can be used to produce stents with as low a profile as possible to allow placement in the largest number of arteries. Further, it is advantageous to have material that can be used to produce a stent in a variety of complex shapes.
  • a biocompatible, expansile material suitable for implantation into the body of an animal, including a human.
  • the material comprises two outer layers of semipermeable substance, and a central layer of hydrophillic substance between the two outer layers. Water passing through the two outer layers of semipermeable substance is absorbed by the central layer causing the material to expand.
  • the one or more than one of the two outer layers comprises material selected from the group consisting of polytetrafluoroethylene, polyurethane and dacron. In another embodiment of the present invention, the one or more than one of the two outer layers comprises microscopic pores or a plurality of slits that allow water to pass through the outer layer.
  • the central layer comprises collagen or comprises agar. Preferably, the expansion of the material increases the thickness from about 10% to about 600% .
  • a biocompatible, expansile material suitable for implantation into the body of an animal, including a human.
  • the material comprises a outer layer of semipermeable substance and a central core of hydrophillic substance surrounded by the outer layer. Water passing through the outer layer of semipermeable substance is absorbed by the central core causing the material to expand.
  • the outer layer comprises a material selected from the group consisting of polytetrafluoroethylene, polyurethane and dacron.
  • the outer layer comprises microscopic pores or a plurality of slits that allow water to pass through the outer layer.
  • the central layer comprises collagen or comprises agar.
  • the expansion of the material increases the thickness from about 10% to about 600%.
  • a biocompatible, expansile material suitable for implantation into the body of an animal, including a human comprising a reinforcing wire surrounded by an outer coil of the material according to the present invention.
  • the reinforcing wire comprises a substance selected from the group consisting of nitinol, platinum, tungsten, and combinations of platinum, tungsten and nitinol.
  • the reinforcing wire has a diameter of between about 0.15 mm and about 1 mm.
  • a biocompatible, expansile material suitable for implantation into the body of an animal, including a human comprising sheets of laterally connected longitudinally arranged linear lengths of a material according to the present invention.
  • a biocompatible, expansile stent suitable for implantation into the body of an animal, including a human.
  • the stent comprises a proximal end and a distal end, and a generally tubular structure made of laterally interconnected, longitudinally arranged linear lengths of the material according to the present invention between the proximal end and distal end.
  • the lateral interconnections are reinforced, such as with polytetrafluoroethylene.
  • the proximal end and distal end have a larger diameter than the portion of the stent between the proximal end and the distal end.
  • a method for effecting patency, maintaining patency or both, of a tubular structure within the body of an animal or human comprises the steps of first, selecting an animal or human having a tubular structure suitable for insertion of a sent according to the present invention. Next, a delivery catheter containing a stent is advanced into the tubular structure to the site of intended placement of the stent. Then, the stent is placed into the tubular structure and allowing the stent to assume an appropriate shape. The stent is allowed to absorb water from the within the tubular structure and expand.
  • the tubular structure in the selected animal or human is a coronary artery.
  • the delivery catheter is removed from the tubular structure.
  • Figure 1 is a top perspective view of a sheet of material according to one embodiment of the present invention before expansion of the material;
  • Figure 2 is a top perspective view of a sheet of material shown in Figure 1 after expansion of the material;
  • Figure 3 is a top perspective view of a sheet of material according to another embodiment of the present invention before expansion of the material;
  • Figure 4 is a top perspective view of a sheet of material shown in Figure 3 after expansion of the material;
  • Figure 5 is a top perspective view of a suture made of material according to one embodiment of the present invention expansion of the material;
  • Figure 6 is a top perspective view of a suture made of material shown in Figure 5, after expansion of the material;
  • Figure 7 is a top perspective, partial cutaway view of another material according to one embodiment of the present invention before expansion of the material;
  • Figure 8 is a top perspective, partial cutaway view of the material shown in Figure 7, after expansion of the material;
  • Figure 9 is a lateral, cross-sectional view of an artery adjacent an aneurysm with a coil of the material according to the present invention placed in the artery adjacent the neck of the aneurysm, before expansion of the material;
  • Figure 10 is a lateral, cross-sectional view of an artery adjacent an aneurysm with a coil of the material according to the present invention placed in the artery adjacent the neck of the aneurysm, after expansion of the material;
  • Figure 11 is a lateral, cross-sectional view of an artery adjacent an aneurysm with a coil of the material according to the present invention placed in the aneurysm, before expansion of the material;
  • Figure 12 is a lateral, cross-sectional view of an artery adjacent an aneurysm with a coil of the material according to the present invention placed in the aneurysm, after expansion of the material;
  • Figure 13 is a top perspective view of another embodiment of the material shown in Figure 7, before implantation;
  • Figure 14 is a top perspective view of another embodiment of the material shown in Figure 7, after implantation;
  • Figure 15 is lateral perspective view of a stent according to one embodiment of the present invention after placement in a tubular structure but before expansion;
  • Figure 16 is a lateral perspective view of the stent shown in Figure 15 after placement is a tubular structure and after expansion;
  • Figure 17 is a lateral perspective view of a stent according to another embodiment of the present invention.
  • Figure 18 is a lateral perspective, cross-sectional view of a tubular structure during delivery of a stent according to the present invention into the tubular structure from a delivery catheter;
  • Figure 19 is a lateral perspective, cross-sectional view of the tubular structure shown in Figure 18 after delivery of the stent but before expansion of the stent;
  • Figure 20 is a lateral perspective, cross-sectional view of the tubular structure shown in Figure 18 after delivery of the stent and after expansion of the stent. DESCRIPTION
  • biocompatible, expansile materials suitable for implantation into the body of an animal, including a human.
  • biocompatible, expansile medical devices suitable for implantation into the body of an animal, including a human. Examples of expansile medical devices include vascular stents, biliary stents, and esophageal stents.
  • methods of implanting the material or devices of the present invention into the body of an animal, including a human are provided.
  • the material 10 comprises two outer layers of semipermeable substance 12 surrounding a central layer 14 of hydrophillic substance.
  • Each outer layer 12 comprises one or more than one biocompatible substance that substantially allows water to pass through the substance.
  • each outer layer 12 comprises polytetrafluoroethylene (PTFE).
  • PTFE polytetrafluoroethylene
  • other substances are also suitable, such as polyurethane or dacron, as will be understood by those in the art with reference to this disclosure.
  • Each outer layer 12 can be formed of a sheet, or can be formed in other shapes.
  • each outer layer 12 comprises microscopic pores 16 that allow water to pass through, as shown in Figure 1 and Figure 2.
  • each outer layer 12 can comprise a plurality of slits 18, as shown in Figure 3 and Figure 4, to allow greater expansion of the material 10 as a whole.
  • the central layer 14 comprises one or more than one hydrophillic substance that is biocompatible, stable in vivo, easily formed into sheets or shapes, and sterilizable. Additionally, the hydrophillic substance absorbs water and expands upon absorbing water.
  • the central layer 14 comprises collagen or comprises agar, a natural hydrocolloid polymer of subunits of galactose extracted from seaweed.
  • the material 10 in manufactured by co-extrusion as will be understood by those with skill in the art with reference to this disclosure. Additionally, the pores 16 or slits 18 can be created by laser cutting.
  • the material 20 can be used for a variety of purposes, such as sutures.
  • the material 20 comprises an outer layer of semipermeable substance 22 surrounding a central core 24 of hydrophillic substance.
  • the outer layer 22 comprises one or more than one biocompatible substance that substantially allows water to pass through the substance.
  • the substance is biocompatible, stable in vivo, easily formed into tubes, and sterilizable.
  • the outer layer 22 comprises polytetrafluoroethylene.
  • other substances are also suitable, such as polyurethane or dacron, as will be understood by those in the art with reference to this disclosure.
  • the outer layer 22 can be formed of a tube having microscopic pores (not shown). However, as shown in Figure 5 and Figure 6, the outer layer 22 preferably comprises a plurality of slits 26 to allow greater expansion of the material 20 as a whole.
  • the central core 24 comprises one or more than one hydrophillic substance that is biocompatible, stable in vivo, easily formed into cylinders, and sterilizable. Additionally, the hydrophillic substance absorbs water and expands upon absorbing water.
  • the central core 24 comprises collagen or comprises agar.
  • other substances are also suitable, as will be understood by those in the art with reference to this disclosure.
  • the material 20 is manufactured by co-extrusion as will be understood by those with skill in the art with reference to this disclosure. Additionally, the slits 26 can be created by laser cutting.
  • the material 30 comprises a reinforcing wire 32 surrounded by an outer coil of the material 20, according to the present invention.
  • the ends of the reinforcing wire 32 are depicted in the figures as being not covered by the material 20 purely for illustration purposes, but would be covered by the material 20 when actually being used.
  • the reinforcing wire 32 comprises one or more than substance that is biocompatible, stable in vivo, easily formed into wires, and sterilizable.
  • the reinforcing wire 32 comprises nitinol, which is a nickel, titanium, oxygen and carbon alloy.
  • the reinforcing wire has a diameter of between about 0.15 mm and about 1 mm, though other gauges are suitable depending on the intended use, as will be understood by those in the art with reference to this disclosure.
  • other substances are also suitable, such as platinum, tungsten, and combinations of platinum, tungsten or nitinol, as will be understood by those in the art with reference to this disclosure.
  • the material 30 in manufactured by production of the material 20, and then, by wrapping the material 20 around the reinforcing wire 32, according to techniques known to those with skill in the art.
  • the material 30 Once the material 30 is implanted into an animal, water passes through the outer layer 22 or the material 20 and is absorbed by the central core 24, causing the central core 24 to expand, and increasing in thickness from about 10% to about 600% .
  • the expanding continues over hours to days rather than seconds, in order to allow the surrounding tissues to adapt to the increasing size of the material 30 gradually, and to allow implantation of the material 30 while the material 30 is in the unexpanded state.
  • the reinforcing wire 32 allows the material 30 to be produced in a variety of shapes, such as a coil, and allows the material 30 to maintain the shape during and after expansion of the material 30.
  • a coil of the material 30 can be used to occlude a blood vessel or other conduit within the body of an animal, or to occlude an aneurysm or an arteriovenous malformation or fistula.
  • FIG. 9 there are shown a lateral, cross-sectional view of an artery 100 adjacent an aneurysm 102 with a coil of the material 30 according to the present invention placed in the artery 100 adjacent the neck of the aneurysm 102, before expansion of the material 30, Figure 9, and after expansion of the material 30, Figure 10.
  • expansion of the material 30 occludes the lumen of the artery 100 adjacent the neck of the aneurysm 102, preventing rupture of the aneurysm 102.
  • FIG. 11 and Figure 12 there are shown, respectively, a lateral, cross-sectional view of an artery 100 adjacent an aneurysm 102 with a coil of the material 30 according to the present invention placed in the aneurysm, before expansion of the material 30, and after expansion of the material 30.
  • expansion of the material 30 occludes the lumen of the aneurysm 102, preventing rupture of the aneurysm 102.
  • FIG. 13 and Figure 14 there are shown, respectively, a top perspective view of another embodiment of the material 30 of the present invention before expansion, and a top perspective view of the material 30 shown in Figure 13, after expansion.
  • the material 30 is formed into sheets of laterally interconnected, longitudinally arranged linear lengths of the material 30. Before implantation, the linear lengths of the material 30 are loosely arranged. After implantation, the linear lengths of the material 30 expand and can be configured to expand sufficiently to create a water tight sheet of material 30.
  • Figure 15 and Figure 16 there are shown, respectively, lateral perspective views of a stent according to one embodiment of the present invention after placement in the tubular structure but before expansion, and after expansion.
  • the stent 40 comprises a proximal end 42 and a distal end 44.
  • the stent 40 comprises a generally tubular structure made of laterally connected longitudinally arranged linear lengths of the material 20 according to the present invention, or more preferably the material 30.
  • Each interconnection 46 can be reinforced, as shown, such as, for example, with polytetrafluoroethylene or using suture material.
  • FIG 17 there is shown a lateral perspective view of a stent 40 according to another embodiment of the present invention.
  • the proximal end 42 and distal end 44 have a larger diameter than the portion of the stent 40 between the proximal end 42 and the distal end 44.
  • FIG. 18 there are shown lateral perspective, cross-sectional views of a tubular structure 104 during delivery of the stent 40 according to the present invention into the tubular structure 104 from a delivery catheter 106, Figure 18, and after delivery of the stent 40 but before expansion of the stent 40, Figure 19, and after delivery of the stent 40 and after expansion of the stent, Figure 20.
  • a method for effecting patency, maintaining patency or both, of a tubular structure within the body of an animal or human comprises, first selecting an animal or human having a tubular structure suitable for insertion of a sent according to the present invention.
  • the tubular structure can be a coronary artery and the human selected can be undergoing angioplasty to treat decreased patency of the coronary artery.
  • a delivery catheter containing a stent according to the present invention can be placed into the tubular structure and advanced to the site of intended placement of the stent. Then, the stent is placed into the tubular structure and allow to assume an appropriate shape. The delivery catheter is removed. Finally, the material comprising the stent absorbs water from the within the tubular structure and expands.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La présente invention concerne un matériau biocompatible expansible (10) convenant à l'implantation dans l'anatomie d'un animal, humain compris. Ce matériau est constitué d'une couche centrale (14) de substance hydrophile prise en sandwich entre deux couches extérieures de substance semi-perméable (12). Ainsi, après avoir traversé les deux couches extérieures de substance semi-perméable (12), l'eau est absorbée par la couche centrale (14), ce qui provoque l'expansion du matériau.
PCT/US2001/022725 2000-07-18 2001-07-18 Matériau biocompatible expansible et stent WO2002005731A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280618A AU2001280618A1 (en) 2000-07-18 2001-07-18 Biocompatible, expansile material and stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21904000P 2000-07-18 2000-07-18
US60/219,040 2000-07-18

Publications (1)

Publication Number Publication Date
WO2002005731A1 true WO2002005731A1 (fr) 2002-01-24

Family

ID=22817580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022725 WO2002005731A1 (fr) 2000-07-18 2001-07-18 Matériau biocompatible expansible et stent

Country Status (2)

Country Link
AU (1) AU2001280618A1 (fr)
WO (1) WO2002005731A1 (fr)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092547A1 (fr) * 2002-05-03 2003-11-13 Boston Scientific Limited Dispositif endoluminal a hypotube
WO2004010878A1 (fr) * 2002-07-31 2004-02-05 Microvention, Inc. Dispositif d'occlusion vasculaire a trois elements coaxiaux
US7014645B2 (en) 1999-10-04 2006-03-21 Microvention Inc. Method of manufacturing expansile filamentous embolization devices
WO2008023160A1 (fr) * 2006-08-23 2008-02-28 Evexar Medical Limited Améliorations apportées à des appareils médicaux ou afférentes à ces derniers
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
CN101978934B (zh) * 2003-07-31 2012-10-03 微排放器公司 多层共轴血管闭塞装置
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US8764788B2 (en) 2002-07-31 2014-07-01 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US9114200B2 (en) 2009-09-24 2015-08-25 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
US9259228B2 (en) 2006-06-15 2016-02-16 Microvention, Inc. Embolization device constructed from expansile polymer
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9381278B2 (en) 2012-04-18 2016-07-05 Microvention, Inc. Embolic devices
CN105877873A (zh) * 2009-01-23 2016-08-24 安多拉米诺科学公司 血管内装置及相关系统和方法
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US9486221B2 (en) 2007-12-21 2016-11-08 Microvision, Inc. Hydrogel filaments for biomedical uses
US9622753B2 (en) 2001-07-20 2017-04-18 Microvention, Inc. Aneurysm treatment device and method of use
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
US10058330B2 (en) 2011-05-11 2018-08-28 Microvention, Inc. Device for occluding a lumen
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
FR3094631A1 (fr) 2019-04-08 2020-10-09 D & D Dispositif de transfert a geometrie variable
US11129695B2 (en) 2015-02-16 2021-09-28 D&D Orthodontic appliance
CN117562706A (zh) * 2023-12-06 2024-02-20 中国化学工程第六建设有限公司 一种可降解静脉滤器及其制备方法
US12187387B2 (en) 2009-04-30 2025-01-07 Microvention, Inc. Polymers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554180A (en) * 1995-07-07 1996-09-10 Aeroquip Corporation Intraluminal stenting graft
US5735897A (en) * 1993-10-19 1998-04-07 Scimed Life Systems, Inc. Intravascular stent pump
US6117168A (en) * 1996-12-31 2000-09-12 Scimed Life Systems, Inc. Multilayer liquid absorption and deformation devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5735897A (en) * 1993-10-19 1998-04-07 Scimed Life Systems, Inc. Intravascular stent pump
US5554180A (en) * 1995-07-07 1996-09-10 Aeroquip Corporation Intraluminal stenting graft
US6117168A (en) * 1996-12-31 2000-09-12 Scimed Life Systems, Inc. Multilayer liquid absorption and deformation devices

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491214B2 (en) 1999-10-04 2009-02-17 Microvention, Inc. Filamentous embolization device with expansible elements
US8603128B2 (en) 1999-10-04 2013-12-10 Microvention, Inc. Filamentous embolization device with expansible elements
US7014645B2 (en) 1999-10-04 2006-03-21 Microvention Inc. Method of manufacturing expansile filamentous embolization devices
US7842054B2 (en) 1999-10-04 2010-11-30 Microvention, Inc. Method of manufacturing expansile filamentous embolization devices
US8562667B2 (en) 2001-07-20 2013-10-22 Microvention, Inc. Aneurysm treatment device and method of use
US9622753B2 (en) 2001-07-20 2017-04-18 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US9539122B2 (en) 2001-07-20 2017-01-10 Microvention, Inc. Aneurysm treatment device and method of use
US8591564B2 (en) 2002-05-03 2013-11-26 Lifeshield Sciences, LLC Hypotube endoluminal device and method
WO2003092547A1 (fr) * 2002-05-03 2003-11-13 Boston Scientific Limited Dispositif endoluminal a hypotube
US7122048B2 (en) 2002-05-03 2006-10-17 Scimed Life Systems, Inc. Hypotube endoluminal device
US7879081B2 (en) 2002-05-03 2011-02-01 Boston Scientific Scimed, Inc. Hypotube endoluminal device and method
WO2004010878A1 (fr) * 2002-07-31 2004-02-05 Microvention, Inc. Dispositif d'occlusion vasculaire a trois elements coaxiaux
AU2003257952B2 (en) * 2002-07-31 2008-02-28 Microvention, Inc. Three element coaxial vaso-occlusive device
US8764788B2 (en) 2002-07-31 2014-07-01 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US8882796B2 (en) 2002-07-31 2014-11-11 Microvention, Inc. Three element coaxial vaso-occlusive device
AU2003257952B8 (en) * 2002-07-31 2008-07-10 Microvention, Inc. Three element coaxial vaso-occlusive device
CN101978934B (zh) * 2003-07-31 2012-10-03 微排放器公司 多层共轴血管闭塞装置
US10499925B2 (en) 2006-06-15 2019-12-10 Microvention, Inc. Embolization device constructed from expansile polymer
US9259228B2 (en) 2006-06-15 2016-02-16 Microvention, Inc. Embolization device constructed from expansile polymer
US11185336B2 (en) 2006-06-15 2021-11-30 Microvention, Inc. Embolization device constructed from expansile polymer
US11160557B2 (en) 2006-06-15 2021-11-02 Microvention, Inc. Embolization device constructed from expansile polymer
US9451963B2 (en) 2006-06-15 2016-09-27 Microvention, Inc. Embolization device constructed from expansile polymer
US10226258B2 (en) 2006-06-15 2019-03-12 Microvention, Inc. Embolization device constructed from expansile polymer
US9877731B2 (en) 2006-06-15 2018-01-30 Microvention, Inc. Embolization device constructed from expansile polymer
US9724103B2 (en) 2006-06-15 2017-08-08 Microvention, Inc. Embolization device constructed from expansile polymer
WO2008023160A1 (fr) * 2006-08-23 2008-02-28 Evexar Medical Limited Améliorations apportées à des appareils médicaux ou afférentes à ces derniers
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US9486221B2 (en) 2007-12-21 2016-11-08 Microvision, Inc. Hydrogel filaments for biomedical uses
US10194915B2 (en) 2007-12-21 2019-02-05 Microvention, Inc. Implantation devices including hydrogel filaments
CN105877873A (zh) * 2009-01-23 2016-08-24 安多拉米诺科学公司 血管内装置及相关系统和方法
US12187387B2 (en) 2009-04-30 2025-01-07 Microvention, Inc. Polymers
US9114200B2 (en) 2009-09-24 2015-08-25 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
US11311377B2 (en) 2010-07-09 2022-04-26 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11883283B2 (en) 2010-07-09 2024-01-30 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9931206B2 (en) 2010-07-09 2018-04-03 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11446140B2 (en) 2010-07-09 2022-09-20 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11259921B2 (en) 2010-07-09 2022-03-01 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11259922B2 (en) 2010-07-09 2022-03-01 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US10058330B2 (en) 2011-05-11 2018-08-28 Microvention, Inc. Device for occluding a lumen
US9381278B2 (en) 2012-04-18 2016-07-05 Microvention, Inc. Embolic devices
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
US10946100B2 (en) 2014-04-29 2021-03-16 Microvention, Inc. Polymers including active agents
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US11129695B2 (en) 2015-02-16 2021-09-28 D&D Orthodontic appliance
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
US11759547B2 (en) 2015-06-11 2023-09-19 Microvention, Inc. Polymers
FR3094631A1 (fr) 2019-04-08 2020-10-09 D & D Dispositif de transfert a geometrie variable
CN117562706A (zh) * 2023-12-06 2024-02-20 中国化学工程第六建设有限公司 一种可降解静脉滤器及其制备方法

Also Published As

Publication number Publication date
AU2001280618A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
WO2002005731A1 (fr) Matériau biocompatible expansible et stent
US20220125572A1 (en) Apparatus and method for fluid flow through body passages
US10881413B2 (en) Systems and methods for embolization of body structures
US8882822B2 (en) Non-thrombogenic stent jacket
EP3116439B1 (fr) Ballonnet de fil d'occlusion gonflable pour applications aortiques
CN102573660B (zh) 脉管闭合装置和方法
JP4864309B2 (ja) グラフト材料の連結装置および連結方法
US4820298A (en) Internal vascular prosthesis
JP5070373B2 (ja) 組枠によって支持される充填構造を有する移植片システムおよびその使用方法
JP2020179216A (ja) 動脈瘤を治療するためのデバイスおよび方法
CA2363314C (fr) Greffe d'endoprothese avec greffon plisse
WO2018156850A1 (fr) Endoprothèse couverte comprenant un verrou de fenestration
CA2446472A1 (fr) Methode et dispositif de traitement d'un site tissulaire vulnerable
JPH11285537A (ja) ワイヤ補強管プロテ―ゼ
EP2001403A2 (fr) Stent intravasculaire installable pour le renforcement d'un anévrisme aortique abdominal
JP2000514336A (ja) 外科用移植物およびそのための送達システム
WO2001066037A2 (fr) Prothese intravasculaire
JP2022525788A (ja) 大動脈解離インプラント
CN105916468A (zh) 串联模块化腔内移植物
AU5274700A (en) Stent-graft with increased flexibility
JP2012516705A (ja) 血管内デバイス、その製造方法およびそれを含むキット
WO2015095378A1 (fr) Endoprothèse et procédé d'utilisation pour assister la formation d'une anastomose
MXPA99010357A (en) Self-expanding endoprosthesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载